Versuchen GOLD - Frei
Let's Prepare Well for Negotiations on Trade in Services
Mint Hyderabad
|June 12, 2025
India Must Make the Most of Its Global Edge in Services Via Talks to Lower Barriers That Are Hard to Quantify
Here are some facts. Today, the share of services in global trade stands at about 25%. More importantly, it is the only category of trade that has expanded at a rapid pace since the financial crisis year of 2008. In recent years, the share of goods in trade has fallen by about 5 percentage points and there has been a corresponding increase in the case of services. This pattern is mirrored in India's case. According to the Economic Survey 2024-25, the share of services in terms of export gross value added (GVA) has increased from around 51% in 2014-15 to around 55% now. Further, it is growth in services trade which has kept India's current account deficit (CAD) at a manageable 2% of GDP. It was the General Agreement of Tariffs and Trade (GATT) that led to a decline in global tariffs. Till recently, except some countries in South Asia, import tariffs were in single digits (before Donald Trump took office in the US). And today, international arguments increasingly revolve around non-tariff barriers (NTBs).
It was a stalemate over NTBs at the World Trade Organization (WTO) that led many countries to take recourse to regional trading arrangements to expand their trade over the last two decades. This has the advantage of going beyond the WTO in new areas. One of these is trade in services.
The General Agreement on Trade in Services (GATS) was based on a 'positive list' approach, where countries only need to make offers when they want to. But this has meant very little forward movement here along the lines of commodity trade negotiations under GATT. Another critical holdback is the lack of reliable data.
Diese Geschichte stammt aus der June 12, 2025-Ausgabe von Mint Hyderabad.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Hyderabad
Mint Hyderabad
Nvidia, Eli Lilly to invest $1 bn in AI lab
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.
1 min
January 13, 2026
Mint Hyderabad
Shadowfax IPO to open next week
Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.
1 min
January 13, 2026
Mint Hyderabad
The US climate cop-out should galvanize others
America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US
2 mins
January 13, 2026
Mint Hyderabad
Toyota pushes for fuel norm clarity
The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.
1 min
January 13, 2026
Mint Hyderabad
Food effect lifts Dec CPI inflation
India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.
1 min
January 13, 2026
Mint Hyderabad
Commissions trump advice in wealth management biz
surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.
2 mins
January 13, 2026
Mint Hyderabad
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Hyderabad
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Hyderabad
Fix GST on capital goods to revive private investment
India faces a paradox today.
3 mins
January 13, 2026
Mint Hyderabad
Feeling tired? It could be too many messages
The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes
4 mins
January 13, 2026
Listen
Translate
Change font size
